Jay A. Levy

Q: What Schools Are Affiliated With Jay A. Levy

Jay A. Levy is affiliated with the following schools: University of Kansas, University of California, San Francisco, Wesleyan University

Jay A. Levy's AcademicInfluence.com Rankings

Jay A. Levy

Philosophy

#2971

World Rank

#4911

Historical Rank

#995

USA Rank

Logic

#933

World Rank

#1515

Historical Rank

#317

USA Rank

philosophy Degrees

Download Badge

Philosophy

Jay A. Levy's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Jay A. Levy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jay A. Levy is an American AIDS and cancer research physician. He is a professor of medicine with specialties in virology and immunology at the University of California, San Francisco . Biography Levy was born in Wilmington, Delaware, with his twin brother, Stuart B. Levy. Levy received his B.A. degree with high honors from Wesleyan University in 1960 and subsequently his M.D. from the College of Physicians and Surgeons at Columbia University in 1965. He conducted research for a year on regeneration in planaria at the Université de Paris on Fulbright and French government fellowships. From 1961 to 1963, he was a Fellow in the School of International and Public Affairs, Columbia University, New York. He completed his internship and residency at the University of Pennsylvania Medical Center from 1965 to 1967.

(See a Problem?)

Jay A. Levy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. (1984) (1411)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation (2010) (1129)
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. (1986) (1037)
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. (2004) (836)
Biologic features of HIV-1 that correlate with virulence in the host. (1988) (695)
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). (1985) (643)
Pathogenesis of human immunodeficiency virus infection (1989) (587)
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients (1996) (556)
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. (1995) (545)
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene (1991) (542)
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. (1996) (469)
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. (2001) (451)
Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. (1985) (443)
Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection (2001) (429)
Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. (1987) (404)
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection (2003) (392)
HIV and the Pathogenesis of AIDS (1994) (370)
Chronic fatigue syndrome: clinical condition associated with immune activation (1991) (348)
Human immunodeficiency viruses. (1986) (346)
Pathogenesis of human immunodeficiency virus infection. (1993) (341)
Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. (1992) (332)
The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. (1989) (331)
Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population (1990) (324)
Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection (2014) (306)
Human immunodeficiency virus can productively infect cultured human glial cells. (1987) (303)
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. (2008) (301)
Use of laboratory tests and clinical symptoms for identification of primary HIV infection (2002) (296)
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. (1991) (288)
Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. (1987) (288)
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. (1987) (277)
HIV pathogenesis and long-term survival. (1993) (275)
Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation (1990) (264)
What to call the AIDS virus? (1986) (262)
CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. (1995) (259)
Human lymphoblastoid lines from lymph node and spleen (1968) (257)
The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. (1987) (250)
Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. (1994) (245)
Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. (1989) (242)
Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. (1987) (236)
AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. (1985) (236)
A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. (1989) (228)
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). (1995) (224)
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. (1996) (222)
Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. (1989) (210)
Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. (1993) (205)
An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. (1993) (203)
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. (1992) (195)
HIV pathogenesis: 25 years of progress and persistent challenges (2009) (194)
Infectious human herpesvirus 8 in a healthy North American blood donor (1997) (184)
Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization (1994) (183)
An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells (1987) (181)
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. (1989) (177)
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles (1990) (176)
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. (1999) (174)
Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. (1985) (173)
Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism (1991) (168)
Condoms prevent transmission of AIDS-associated retrovirus. (1986) (168)
Human immunodeficiency viruses. (1996) (167)
Differential ability of human immunodeficiency virus isolates to productively infect human cells. (1987) (161)
Distinct biological and serological properties of human immunodeficiency viruses from the brain (1988) (159)
α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors (2003) (157)
Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. (1994) (157)
Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals (1990) (154)
Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. (1985) (153)
The search for the CD8+ cell anti-HIV factor (CAF). (2003) (152)
The importance of the innate immune system in controlling HIV infection and disease. (2001) (151)
The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. (1988) (151)
Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. (1985) (146)
Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. (1988) (145)
Molecular cloning of AIDS-associated retrovirus (1984) (143)
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120 (1991) (142)
Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. (1995) (138)
The Unexpected Pleiotropic Activities of RANTES (2009) (138)
ACQUIRED IMMUNODEFICIENCY SYNDROME IS AN OPPORTUNISTIC INFECTION AND KAPOSI'S SARCOMA RESULTS FROM SECONDARY IMMUNE STIMULATION (1983) (138)
Demonstration of Biological Activity of a Murine Leukemia Virus of New Zealand Black Mice (1970) (136)
Human immunodeficiency viruses and the pathogenesis of AIDS. (1989) (135)
Mysteries of HIV: challenges for therapy and prevention (1988) (135)
Human herpesvirus 8 detection in nasal secretions and saliva. (1998) (134)
HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. (2005) (132)
Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. (1987) (131)
Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection (1994) (131)
Immunologic abnormalities associated with chronic fatigue syndrome. (1994) (126)
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals (1994) (126)
A Conserved Domain and Membrane Targeting of Nef from HIV and SIV Are Required for Association with a Cellular Serine Kinase Activity (*) (1995) (125)
Studies with hydroxyurea. I. The reversible inhibition of bacterial DNA synthesis and the effect of hydroxyurea on the bactericidal action of streptomycin. (1966) (124)
AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. (1986) (122)
Features of HIV-1 that could influence maternal-child transmission. (1994) (121)
Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome (1990) (120)
No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected (2011) (115)
HYDROXYUREA: A SPECIFIC INHIBITOR OF DEOXYRIBONUCLEIC ACID SYNTHESIS. (1965) (114)
The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue (1990) (113)
Infection by human immunodeficiency virus--CD4 is not enough. (1996) (110)
Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. (1986) (110)
Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells (1988) (109)
The restricted cellular host range of human herpesvirus 8 (2000) (109)
Xenotropic type C viruses. (1978) (107)
The transmission of AIDS: the case of the infected cell. (1988) (107)
An AIDS-like condition induced in baboons by HIV-2. (1994) (104)
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. (1986) (103)
Autoimmunity and neoplasia. The possible role of C-type viruses. (1974) (102)
Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. (1987) (100)
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. (1988) (100)
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. (1985) (100)
Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. (1996) (99)
Oral hairy leukoplakia in an HIV-negative renal transplant recipient. (1989) (98)
CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. (1989) (96)
Role of β-Chemokines in Suppressing HIV Replication (1996) (93)
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. (2006) (92)
The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. (1986) (90)
Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation (1995) (90)
Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. (1991) (90)
Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. (1994) (86)
CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. (1991) (84)
Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. (2004) (83)
Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral Therapy (2006) (82)
Protection from HIV/AIDS: the importance of innate immunity. (2003) (82)
CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. (1990) (79)
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment (2006) (78)
Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture (1990) (78)
Virological and Immunological Features of Long-Term Human Immunodeficiency Virus-Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency Syndrome (1998) (76)
Do beta-chemokines have clinical relevance in HIV infection? (1997) (75)
AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations. (1986) (74)
Viral studies of chronic fatigue syndrome. (1994) (74)
Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells (1966) (71)
Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. (1999) (69)
Differential Transmission of HIV Traversing Fetal Oral/Intestinal Epithelia and Adult Oral Epithelia (2011) (69)
Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera. (1975) (69)
Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice (1975) (69)
Plasma Viral Load, CD4+ Cell Counts, and HIV-1 Production by Cells (1996) (67)
CD28 costimulation increases CD8+ cell suppression of HIV replication. (1997) (67)
HIV Pathogenesis: Knowledge Gained after Two Decades of Research (2006) (67)
Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual. (1990) (66)
Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. (1998) (65)
Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in (NZB x NZW)F1 mice. (1985) (65)
The transmission of HIV and factors influencing progression to AIDS. (1993) (64)
Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice. (1982) (63)
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. (1993) (63)
Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression (2007) (63)
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees (1987) (63)
Detection of HIV in enterochromaffin cells in the rectal mucosa of an AIDS patient. (1989) (63)
Mannose transfer to lipid linked di-N-acetylchitobiose. (1974) (63)
Elimination of infectious retroviruses during preparation of immunoglobulins (1986) (63)
Virus-like particles in placentas from normal individuals and patients with systemic lupus erythematosus. (1977) (62)
MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). (1988) (61)
Patterns of antibody response in individuals infected with the human immunodeficiency virus. (1987) (61)
Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines. (1998) (60)
Lack of response to suramin in patients with AIDS and AIDS-related complex. (1987) (60)
CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. (1998) (59)
A Single Amino Acid of the Human Immunodeficiency Virus Type 2 Capsid Affects Its Replication in the Presence of Cynomolgus Monkey and Human TRIM5αs (2007) (59)
HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. (2011) (58)
Caution: should we be treating HIV infection early? (1998) (57)
Human herpesvirus 8 in semen and prostate. (1997) (57)
Does HIV cause salivary gland disease? (1989) (56)
Host range of murine xenotropic virus: replication in avian cells (1975) (56)
Normal human placentas contain RNA-directed DNA polymerase activity like that in viruses. (1978) (56)
Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. (1985) (56)
Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. (1992) (55)
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV‐1SF2 (1995) (55)
HIV and the Pathogenesis of AIDS, Third Edition (2007) (54)
Small animals are not susceptible to human immunodeficiency virus infection. (1987) (54)
Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development (2001) (54)
Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. (1991) (53)
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. (2006) (52)
The value of primate models for studying human immunodeficiency virus pathogenesis (1996) (52)
Murine Sarcoma Virus: The Question of Defectiveness (1970) (52)
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. (1989) (52)
Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus. (1995) (51)
Natural type 1 interferon producing cells in HIV infection. (2002) (50)
Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. (1977) (50)
CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. (2000) (49)
HIV/AIDS: 30 Years of progress and future challenges (2011) (49)
Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4 (1993) (49)
Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. (1989) (49)
Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. (1991) (48)
Studies of FBJ osteosarcoma virus in tissue culture. I. Biologic characteristics of the "C"-type viruses. (1973) (48)
HIV replication can be blocked by recombinant human interferon beta. (1989) (48)
Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. (1985) (48)
Role of IL-16 in HIV replication (1996) (48)
Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. (1994) (47)
Further studies on a glycolipid formed from dolichyl-D-glucosyl monophosphate. (1973) (47)
Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. (1991) (47)
HIV heterogeneity and viral pathogenesis. (1988) (46)
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice (1997) (46)
Natural Suppression of Human Immunodeficiency Virus Type 1 Replication Is Mediated by Transitional Memory CD8+ T Cells (2010) (46)
Possible communication between murine macrophages oriented in linear chains in tissue culture. (1976) (46)
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. (2001) (45)
Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. (1994) (45)
Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. (1990) (45)
CD8+ cells from HIV‐2‐infected baboons control HIV replication (1997) (45)
Several CD4 domains can play a role in human immunodeficiency virus infection in cells (1991) (45)
Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. (2003) (45)
Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment. (1989) (45)
Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains. (1990) (44)
Altered host range of HIV-1 after passage through various human cell types. (1991) (44)
Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages (1993) (43)
Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. (1979) (43)
Murine xenotropic type C viruses. III. Phenotypic mixing with avian leukosis and sarcoma viruses. (1977) (41)
Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. (1988) (41)
Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome. (1985) (41)
Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells. (1991) (41)
Registration of clinical trials. (2005) (41)
Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact. (1986) (41)
Induction of human herpesvirus-8 gene expression by recombinant interferon gamma. (2000) (41)
Indirect immunofluorescence assay for antibodies to human immunodeficiency virus (1987) (40)
HLA Compatibility Requirements for CD8+-T-Cell-Mediated Suppression of Human Immunodeficiency Virus Replication (1998) (40)
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. (2002) (39)
Increased Virus Replication and Virulence after Serial Passage of Human Immunodeficiency Virus Type 2 in Baboons (2003) (39)
Human immunodeficiency viruses [letter] (1986) (39)
The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors (2003) (37)
Prevalence of antibodies to the human immunodeficiency virus in Dominicans and Haitians in the Dominican Republic. (1987) (37)
HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. (1992) (36)
Demonstration of differences in murine sarcoma virus foci formed in mouse and rat cells under a soft agar overlay. (1971) (36)
Optimal conditions for synthesizing complementary DNA in the HIV‐1 endogenous reverse transcriptase reaction (1990) (36)
Changing concepts in HIV infection: challenges for the 1990s. (1990) (36)
CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. (1996) (36)
Nutrition and autoimmunity: a review. (1986) (35)
Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15. (2004) (35)
Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus (1996) (35)
The multifaceted retrovirus. (1986) (35)
Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. (1982) (34)
Neutralization of mouse xenotropic virus by lipoproteins involves binding to the virions. (1988) (34)
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain (1993) (33)
Potential for transmission of AIDS-associated retrovirus from bisexual men in San Francisco to their female sexual contacts. (1986) (33)
A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. (2007) (33)
High CD8+ T Cell Activation Marks a Less Differentiated HIV-1 Specific CD8+ T Cell Response that Is Not Altered by Suppression of Viral Replication (2009) (33)
An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. (1994) (32)
Recovery of human immunodeficiency virus from serum. (1987) (31)
Condoms prevent transmission of AIDS-associated retrovirus [letter] (1986) (31)
Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns. (2000) (31)
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination. (1999) (31)
Murine xenotropic type C viruses. II. Phenotypic mixing with mouse and rat ecotropic type C viruses. (1977) (30)
Small cell undifferentiated carcinoma of the colon associated with hepatocellular carcinoma in an immunodeficient patient. (1996) (30)
Presence of EBV Antibodies in Sera from Wild Chimpanzees (1971) (30)
Site-selective growth of a hormone-responsive human breast carcinoma in athymic mice. (1982) (29)
Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice. (1985) (29)
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection. (2004) (29)
Assessment and diagnostic utility of the cytotoxic T-lymphocyte phenotype using the specific markers granzyme-B and TIA-1 in esophageal mucosal biopsies. (1999) (29)
Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. (2000) (29)
Endogenous C-type viruses: double agents in natural life processes. (1976) (28)
What can be achieved with an HIV vaccine? (2001) (28)
Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. (1991) (28)
Further characterization of the WI-L1 and WI-L2 lymphoblastoid lines. (1971) (28)
Is HIV superinfection worrisome? (2002) (28)
AIDS : pathogenesis and treatment (1989) (27)
Biologic and molecular properties of the AIDS-associated retrovirus that affect antiviral therapy (1987) (27)
Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response. (1997) (27)
Type C virus expression and host response in diet-cured NZB/W mice (1977) (26)
Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. (2013) (26)
Characteristics of HIV infection and pathogenesis. (1989) (26)
HIV (Human Immunodeficiency Virus) (2002) (25)
Detection of human immunodeficiency virus (HIV) in serum and body fluids by sequential competition ELISA. (1988) (25)
A randomized, controlled trial of mindfulness-based stress reduction in HIV infection (2018) (25)
Role of beta-chemokines in suppressing HIV replication. (1996) (25)
Recovery of xenotropic virus but not ecotropic virus during graft-versus-host reaction in mice. (1977) (24)
Lack of requirement of murine leukemia virus for early steps in infection of mouse embryo cells by murine sarcoma virus. (1971) (24)
Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. (2005) (24)
Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. (2003) (23)
Human immunodeficiency virus infection of the CNS: characterization of "neurotropic" strains. (1990) (23)
Correction: Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression (2007) (23)
Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice. (1986) (22)
Differential Effects of Human Immunodeficiency Virus Isolates on β-Chemokine and Gamma Interferon Production and on Cell Proliferation (1999) (22)
Endogenous C-type viruses in normal and "abnormal" cell development. (1977) (22)
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART (2004) (22)
Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. (1996) (22)
Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus. (1988) (21)
HIV-1 Vaccine Trials: Evolving Concepts and Designs (2012) (21)
Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. (1998) (21)
Recovery of murine xenotropic type-C virus from C57L mice. (1974) (21)
The importance of DNA size for successful transfection of chicken embryo fibroblasts. (1974) (21)
The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes (1996) (21)
Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS. (1987) (20)
Effect of zidovudine therapy on CD8+ T cell anti-HIV activity. (1994) (20)
Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual. (1988) (20)
Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons. (1999) (20)
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. (1998) (20)
Recovery and inactivation of infectious retroviruses from factor VIII concentration. (1984) (20)
Spore Germination and Carbon Metabolism in Fusarium solani. III. Carbohydrate Respiration in Relation to Germination. (1963) (20)
Human placentas contain a specific inhibitor of RNA-directed DNA polymerase. (1981) (19)
Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. (1991) (19)
CONVERSION OF LYSOGENIC ESCHERICHIA COLI BY NONMULTIPLYING, SUPERINFECTING BACTERIOPHAGE P2. (1964) (19)
Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines. (1999) (19)
Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons. (1998) (19)
Transfection optimization for primary human CD8+ cells. (2011) (19)
The HIV‐1 nef gene product is associated with phosphorylation of a 46 kD cellular protein (1992) (18)
Primary HIV-1 infection. (1991) (18)
Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates. (1993) (18)
Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV replication. (2007) (18)
Not an HIV cure, but encouraging new directions. (2009) (18)
Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids. (1984) (18)
Surrogate markers in AIDS research. Is there truth in numbers? (1996) (18)
Acquired immunodeficiency syndrome and cancer (1985) (18)
Freeze-drying is an effective method for preserving infectious type C retroviruses. (1982) (18)
Differential gene expression in CD8+ cells exhibiting noncytotoxic anti-HIV activity. (2003) (17)
High Titre T Antigen with Minimal Amounts of Structural Antigen in Adenovirus-infected Cells treated with Hydroxyurea (1968) (17)
Risk of Transmitting the Human Immunodeficiency Virus, Cytomegalovirus, and Hepatitis B Virus to Health Care Workers Exposed to Patients With AIDS and AIDS-Related Conditions (1987) (17)
Parameters involved in the cell fusion induced by HIV (1990) (17)
Differential effects of CD28 costimulation on HIV production by CD4+ cells. (1998) (17)
Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine. (1994) (16)
Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine. (2004) (16)
Infection of cultured human adrenal cells by different strains of HIV (1992) (16)
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2. (1996) (16)
Risk of seroconversion for acquired immunodeficiency syndrome (AIDS) in San Francisco health workers. (1986) (16)
Effect of low dietary lipid on the development of Sjögren's syndrome and haematological abnormalities in (NZB x NZW)F1 mice. (1989) (16)
Infection of baboons with simian/human immunodeficiency viruses. (1995) (16)
Infection by the Retrovirus Associated With the Acquired Immunodeficiency Syndrome: Clinical, Biological, and Molecular Features (1986) (15)
HIV and host immune responses in AIDS pathogenesis (1993) (15)
Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS (1987) (15)
Derivation ofHerpesvirus saimiri-Transformed CD8+T Cell Lines with Noncytotoxic Anti-HIV Activity (1997) (15)
HIV virions and HIV infection in vitro are unaffected by human granzymes A and B. (2000) (15)
Xenotropism: the elusive viral receptor finally uncovered. (1999) (15)
VCAM-1 Expression on CD8+ Cells Correlates with Enhanced Anti-HIV Suppressing Activity1 (2005) (14)
Enhanced AKR leukemogenesis by the dual tropic viruses. I. The time and site of origin of potential leukemic cells. (1987) (14)
Murine xenotropic type C viruses. V. Biologic and structural differences among three cloned retroviruses isolated from kidney cells from one NZB mouse. (1984) (14)
Chemically Modified Peptides Based on the Membrane-Proximal External Region of the HIV-1 Envelope Induce High-Titer, Epitope-Specific Nonneutralizing Antibodies in Rabbits (2014) (14)
Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells. (1991) (14)
Failure to Confirm the Presence of a Retrovirus in Cultured Lymphocytes from Patients with Kawasaki Syndrome (1991) (14)
Human Immunodeficiency Virus (HIV) From Experimentally Infected Chimpanzees: Isolation and Characterization (1989) (13)
Differential effect of dexamethasone on replication of ecotropic and xenotropic mouse type C viruses. (1979) (13)
Dispelling myths and focusing on notable concepts in HIV pathogenesis. (2015) (13)
Virus-Host Interactions in HIV Pathogenesis (2011) (13)
Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication. (1992) (13)
CD8+ Cell Anti-HIV Activity Rapidly Increases Upon Discontinuation of Early Antiretroviral Therapy (2009) (13)
Sacral epithelioid angiosarcoma associated with a bleeding diathesis and spinal epidural hematoma: case report. (2006) (13)
In vitro cultivation of a chemically induced epidermal carcinoma: establishment of three cell lines and isolation of murine leukemia virus. (1973) (13)
FBJ osteosarcoma virus in tissue culture. III. Isolation and characterization of non-virus-producing FBJ-transformed cells (1978) (13)
Occurrence of reovirus antibodies in healthy African children and in children with Burkitt's lymphoma (1968) (12)
The CD8+ T Cell Noncytotoxic Antiviral Responses (2021) (12)
HIV-1: hitching a ride on erythrocytes (2002) (12)
Effect of IL-2 Therapy on CD8+ Cell Noncytotoxic Anti-HIV Response During Primary HIV-1 Infection (2004) (12)
Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus. (1986) (12)
HIV virions and HIV replication are unaffected by granulysin. (2000) (12)
Maternally transmitted HIV infection in children. (1988) (12)
Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response. (2008) (12)
Absence of antibodies to the human immunodeficiency virus in sera from Africa prior to 1975. (1986) (12)
Contact tracing in the acquired immune deficiency syndrome (AIDS): Evidence for transmission of virus and disease by an asymptomatic carrier (1984) (12)
Virucidal Efficacy of Soap and Water against Human Immunodeficiency Virus in Genital Secretions (2003) (11)
Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity. (1997) (11)
Antibodies to AIDS-associated retrovirus distinguish between pediatric primary and acquired immunodeficiency diseases. (1985) (11)
A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses. (2005) (11)
Differences in lymphomagenic properties of AKR mouse retroviruses. (1984) (11)
Potential herpesvirus interaction during HIV type 1 primary infection. (2005) (11)
The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication. (1999) (11)
IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (TH17) Cells in the Periphery (2010) (11)
Laboratory investigation of pediatric acquired immunodeficiency syndrome. (1986) (11)
Purification of a specific inhibitor of reverse transcriptase from human placenta (1984) (10)
CD26 is not involved in infection of peripheral blood mononuclear cells by HIV-1. (1994) (10)
Association of Murine Leukaemia Virus from a Mouse Lymphoma (2731/L) with Reovirus Type 3 Infection (1970) (10)
Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. (2001) (10)
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy. (2001) (10)
The pathogenesis of HIV infection. (1990) (10)
Transfer of mouse anti-xenotropic virus neutralizing factor to human lipoproteins (1982) (10)
Genetics of xenotropic virus expression in mice. I. Evidence for a single locus regulating spontaneous production of infectious virus in crosses involving NZB/B1NJ and 129/J strains of mice (1979) (9)
Studies of FBJ osteosarcoma virus in tissue culture. II. Autoinhibition of focus formation. (1975) (9)
Long-term survivors of HIV infection. (1994) (9)
Mouse sperm can horizontally transmit type C viruses. (1980) (9)
Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease. (1999) (9)
Effect of Reovirus Type 3 on Cultured Burkitt's Tumour Cells (1968) (9)
Type C Virus Inhibitor Associated with Cells Cultivated from New Zealand Black Mice (1975) (9)
Xenotropic C-type viruses and autoimmune disease. (1975) (9)
The human immunodeficiency virus, type 1: the virus and its role in neurologic disease. (1992) (9)
Relationship of endogenous murine xenotropic type C virus production to spontaneous transformation of cultured cells. (1978) (8)
Prospects for an AIDS vaccine: encourage innate immunity. (2004) (8)
25 Years of AIDS: recording progress and future challenges. (2012) (8)
The human immunodeficiency virus and its pathogenesis. (1988) (8)
The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells. (2016) (8)
Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element. (2002) (8)
Dietary regulation of the autoimmune process in murine lupus. (1983) (8)
Unusual characteristics of peritoneal macrophages from aged autoimmune-prone mice. (1982) (7)
Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor (2015) (7)
Protease inhibitors do not increase the CD4+ cell count in HIV-uninfected individuals. (1998) (7)
Enhanced AKR leukemogenesis by the dual tropic viruses. II. Effect on cell-mediated immune responses. (1987) (7)
Inactivation of murine RNA tumor viruses by isatin beta-thiosemicarbazone, its derivatives and analogs. (1976) (7)
Cancer, AIDS, and Quality of Life (1997) (7)
Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection. (2020) (7)
Inhibition of protein synthesis by the human immunodeficiency virus type 1 nef gene product. (1994) (6)
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. (1989) (6)
Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures. (1983) (6)
Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons. (2003) (6)
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection (2005) (6)
Evolutionarily Conserved Epitopes on Human Immunodeficiency Virus Type 1 (HIV-1) and Feline Immunodeficiency Virus Reverse Transcriptases Detected by HIV-1-Infected Subjects (2013) (6)
The human immunodeficiency viruses. Detection and pathogenesis. (1989) (6)
Discovery, Structure, Heterogeneity, and Origins of HIV (2007) (6)
Inhibition of HIV replication by trichosanthin in peripheral blood mononuclear cells (1994) (5)
Optimal conditions for detection of reverse transcriptase activity in human placentas. (1984) (5)
The effect of altered lymphocyte function on the immunologic disorders of NZB/NZW mice. Response to anti-thymocyte globulin. (1977) (5)
Optimal Conditions forRecovery oftheHumanImmunodeficiency Virus fromPeripheral BloodMononuclear Cells (1988) (5)
Features of Human Immunodeficiency Virus Infection and Disease (1993) (5)
Transformation of macrophages from NZB hybrid mice by simian virus 40. (1981) (5)
Fas and Fas ligand are not involved in the suppression of HIV replication by CD8 cells. (2000) (5)
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. (2007) (5)
Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects (2015) (5)
AIDS and related conditions: One year's experience in St Vincent's Hospital, Sydney (1984) (5)
The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes. (2001) (5)
Generation of HIV-1-infected patients' gene-edited induced pluripotent stem cells using feeder-free culture conditions. (2020) (5)
Effect of HIV on Various Tissues and Organ Systems in the Host (2007) (5)
Erratum: (Retracted article): Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase (AIDS (2002) 14 (827-838)) (2004) (5)
The effect of ethidium bromide on C type virus production and induction. (1979) (5)
Distinction between envelope antigens of murine xenotropic and ecotropic type C viruses by immunoelectron microscopy. (1977) (4)
Recovery of three distinct biologically active type C viruses from cloned C57Bl/6 melanoma cells. (1979) (4)
Primary CD 8 1 cells from HIV-infected individuals can suppress productive infection of macrophages independent of b-chemokines (1998) (4)
AIDS and HIV Infection after Thirty Years (2013) (4)
Murine xenotropic type C viruses. IV. Replication and pathogenesis of ducks. (1982) (4)
Sensitivity of human immunodeficiency virus infection to various α , β and γ chemokines (1999) (4)
Potential Screening Assay for Undetectable Viruses on the Basis of Their Capacity To Induce Alpha Interferon Production (2004) (4)
Technical Advances in AIDS Research in the Human Nervous System (1995) (4)
Overall Features of HIV Pathogenesis: Prognosis for Long-Term Survival (2007) (4)
Virus-Host Interactions in HIV Pathogenesis: directions for therapy (2011) (4)
Productive infection of embryonal carcinoma cells with ecotropic mouse type C viruses and subsequent arrest of differentiation. (1982) (3)
HIV research and nef alleles. (1991) (3)
Genetically edited CD34+ cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells (2021) (3)
HIV neuropathogenesis. (1997) (3)
Small Regions of the env and tat Genes Control Cellular Tropism, Cytopathology and Replicative Properties of HIV-1 (1992) (3)
The Retroviridae. Volume 1. (1992) (3)
Susceptibility of peripheral blood mononuclear cells from gorillas, orangutans and baboons to diverse HIV isolates. (1996) (3)
Rapid Publication CD 8 + Cell Anti-HIV Activity Correlates with the Clinical State of the Infected Individual (3)
Steps Involved in HIV:Cell Interaction and Virus Entry (2007) (3)
Acute HIV Infection and Cells Susceptible to HIV Infection (2007) (2)
Differentiated mouse epithelial cell line with hepatocyte characteristics. (1982) (2)
Generation of HIV-1 infected patient's gene-edited iPSC using feeder free culture conditions. (2020) (2)
CD8+ cell noncytotoxic antiviral response in long-term HIV-1 infected former blood donors in China. (2009) (2)
The viral etiology of AIDS (1985) (2)
V 3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1 (2005) (2)
Cats and Cancer (1974) (2)
HIV Testing and Education Promote Safe Sex Among Urban Women in Rwanda (1990) (2)
Innate Immune Responses in HIV Infection (2007) (2)
Reduction in AIDS virus transmission: seroconversion in San Francisco 1982-1985 [abstract] (1986) (2)
HIV infection: what should be considered in approaches for a cure? (2012) (2)
Viral and immunological factors involved in HIV neuropathogenesis (1996) (2)
Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency. (1996) (2)
Indirect immunofluorescence assays can readily detect antibodies to the human immunodeficiency virus. (1987) (2)
Dietary fat and autoimmune disease. (1983) (2)
New and old immunodeficiencies. Discussion (1993) (1)
CHAPTER 22 – Phenotypic Mixing among Type C Viruses: Mechanism for Virus Spread, Somatic Mutation, and Oncogenesis (1978) (1)
The CD 8 + cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD 4 + cells (2016) (1)
The CD8 cell antiviral factor: an interview with immunologist Jay Levy, MD. Interview by Mark Mascolini. (1995) (1)
Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4. (1996) (1)
Changing Dogmas in Retrovirology (1985) (1)
Viral and cellular factors influencing HIV tropism. (1991) (1)
Can an AIDS vaccine be developed? (1988) (1)
Antibodies to the AIDS-associated retrovirus in hemophiliacs and other individuals from southern Spain: lack of correlation with lymphocytes sub-populations. (1984) (1)
Retroviridae : Human Immunodeficiency Viruses (1988) (1)
The retroviridae: Volume 3. (1994) (1)
Features of HIV Transmission (2007) (1)
Mechanism of CD4+ Cell Killing by the Human Immunodeficiency Virus (1989) (1)
Genetics of Xenotropic Virus Expression in Mice. II. Expression of Major Virus Structural Proteins in Crosses Involving NZB/BINJ, SWR/J, and 129/J Strains of Mice 1 (1983) (1)
Intracellular Control of HIV Replication (2007) (1)
[Demonstration of an antiviral substance in the culture medium of cells of the NZB mouse]. (1973) (1)
Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. (2004) (1)
Life span of MRL/lpr/lpr mice. (1985) (1)
Are type C viruses transforming agents? (1981) (1)
Selection of conserved HIV-1 vaccine epitopes based on cross-reactivity to feline immunodeficiency virus (53.17) (2011) (1)
Innate Cellular Immune Responses in HIV Infection (2007) (1)
Features of Human Immunodeficiency Virus Infection and Disease (1993) (1)
Lack of the CD 8 cell anti-HIV factor in CD 8 cell granules (2003) (1)
The need to reassess our approaches at HIV cure and prevention. (2020) (1)
responses: the role of IL-15 Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV (2013) (0)
AIDS-associated retrovirus (ARV) and lymphadenopathy (1985) (0)
AIDS new editor announcement. (2016) (0)
Note from the Editors. (2017) (0)
Infection of mouse teratocarcinoma cells with mouse type c viruses. Abstr. (1980) (0)
RAPID CD4 T CELL DEPLETION IN HUMAN-PBL-SCID MICE BY NON-CYTOPATHIC MACROPHAGE-TROPIC ISOLATES OF HIV (2017) (0)
T-Lymphocyte Immune Responses in HIV Infection (2007) (0)
Xenotropism: The elusive viral rece (2016) (0)
Letter from Jay A. Levy, University of California, San Francisco School of Medicine to Harold Varmus (1985) (0)
The Retroviridae (1993) (0)
Xenotropic C-type viruses and autoimmune disease. (1984) (0)
How Does Basic Research in Cancer and AIDS Approach the Concern for Quality of Life (1997) (0)
Early treatment of HIV-1 infection (1998) (0)
Title IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD 4 + T ( TH 17 ) Cells in the Periphery Permalink (2010) (0)
Title CD 8 + Cell Anti-HIV Activity Rapidly Increases Upon Discontinuation of Early Antiretroviral Therapy (2009) (0)
EARLY TREATMENT OF HIV-1 INFECTION. AUTHOR'S REPLY (1998) (0)
Differences in biologic properties among three clones of xenotropic viruses isolated from nzb kidney cells. Abstr. (1983) (0)
Scanning the headlines with Jay A. Levy, MD. Interview by Mark Mascolini. (1996) (0)
HIV Infection and Development of Cancer (2007) (0)
Nevirapine Inhibits the Anti-HIV Activity of CD8+ Cells (2013) (0)
Xenotropic virus expression and susceptibility to 3-methylcholanthrene-induced cancer. (1980) (0)
Significance of natural neutralizing antibodies to murine xenotropic virus. Abstr. (1975) (0)
Activated CD28-positive CD8-positive T cell phenotype correlates with anti-HIV suppressing activity and asymptomatic clinical status (1993) (0)
The CD8 (cid:1) cell noncytotoxic anti-HIV response can be blocked by protease inhibitors (2003) (0)
IDENTIFICATION OF CELLULAR AND VIRAL GENES POTENTIALLY INVOLVED IN HUMAN HERPESVIRUS (HHV)-8 PATHOGENESIS. (1998) (0)
HIV Infection in the Dominican Republic-Reply (1987) (0)
AIDS: Editorial update (2011) (0)
Professor Ronald Penny (2020) (0)
Homage to Mark Wainberg (2017) (0)
Controversies: Does the CD4+ Cell Count Reflect Clinical Efficacy?-Reply (1996) (0)
HIV-1 Strain-dependent CD4 T Cell Depletion in hu-PBL-SCID Mice (1993) (0)
Perspectivesin CancerResearch The Multifaceted Retrovirus1 (2006) (0)
Modifications of estradiol binding and tumor growth by cannabinol and cannabidol (1981) (0)
Viral Proteins Determining Biologic Features of HIV (2007) (0)
Natural Suppression of Human Immunodeﬁciency Virus Type 1 Replication Is Mediated by Transitional Memory CD8 (cid:1) T Cells (cid:1) (2011) (0)
AIDS new editor announcement. (2020) (0)
HIV infection in infants of IV drug abusing women (1990) (0)
The Retroviridae (1992) (0)
To the AIDS readership (2000) (0)
Cytopathic Properties of HIV (2007) (0)
The Retroviridae (1995) (0)
P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses (2009) (0)
Correlates with Enhanced Anti-HIV Cells + VCAM-1 Expression on CD 8 (2005) (0)
Endogenous C-type Viruses in Normal and â€œAbnormalâ€(cid:157)Cell Development1 (2006) (0)
Uncloaking Hidden Viruses (2000) (0)
Influence of dietary fat on immune complex disease and immunologic function. Abstr. (1980) (0)
Mouse xenotropic viruses can inhibit cell transformation. (1987) (0)
[Immunofluorescence test in the diagnosis of AIDS-associated virus infection in Norway]. (1986) (0)
Humoral Immune Responses to HIV Infection (2007) (0)
HOST RANGE STUDIES OF HUMAN HERPESVIRUS 8 (HHV8): 73 (1997) (0)
Surprises in diagnosis (2001) (0)
HIV: A Decade of Research (1995) (0)
This information is current as Cells + HIV Production by CD 4 Differential Effects of CD 28 Costimulation on (1998) (0)
The AIDS vaccine: who can take the lead? Cohen Jon Shots (2001) (0)
Association of a [corrected] murine leukaemia virus from a mouse lymphoma (2731-L) associated [corrected] with reovirus type 3 infection. (1970) (0)
Response from Winkelstein, et al (1987) (0)
Virucidal Efficacy of Soap and Water against Human Immunodeficiency Virus in Genital Secretions (2004) (0)
The Influence of Nutrition on Experimental Autoimmune Disease (2020) (0)
Abstract IA36: HIV, HTLV, and EBV infection and the development of cancer (2017) (0)
The Retroviridae, volume 2. (1993) (0)
P-C2 T-cell based lentiviral vaccines (2016) (0)
HIV-infected chimpanzees. virus (HIV) and its recombinant antigens in T-cell responses to human immunodeficiency (2013) (0)

This paper list is powered by the following services:

Other Resources About Jay A. Levy

en.wikipedia.org

What Schools Are Affiliated With Jay A. Levy?

Jay A. Levy is affiliated with the following schools:

Jay A. Levy's Academic­Influence.com Rankings